All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial
Autor: | Huang, Qiu-Sha, Liu, Yi, Wang, Jing-Bo, Peng, Jun, Hou, Ming, Liu, Hui, Feng, Ru, Wang, Jing-Wen, Xu, Lan-Ping, Wang, Yang, Huang, Xiao-Jun, Zhang, Xiao-Hui * |
---|---|
Zdroj: | In The Lancet Haematology October 2021 8(10):e688-e699 |
Databáze: | ScienceDirect |
Externí odkaz: |